Sun Wei-Jhe, Aburub Aktham, Sun Changquan Calvin
Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 308 Harvard Street S.E., Minneapolis, Minnesota 55455.
Small Molecule Design and Development, Lilly Research Labs, Eli Lilly and Company, Indianapolis, Indiana 46285.
J Pharm Sci. 2017 Jul;106(7):1772-1777. doi: 10.1016/j.xphs.2017.03.005. Epub 2017 Mar 16.
Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.
对于低剂量口服片剂而言,尤其是采用直接压片法(DC)时,保持良好的含量均匀度(CU)是一项重大挑战。我们使用6种模型活性药物成分表明,可以开发出一种适用于开发具有优异CU的低剂量活性药物成分的直接压片平台片剂配方。这种平台配方通过颗粒工程实现,即将感兴趣的活性药物成分负载在合适的多孔载体中,以形成均匀的活性药物成分-载体复合物。此类复合颗粒的粉末性质由载体的性质决定,而载体性质对活性药物成分的化学结构和负载水平不敏感。粉末流动性、可压性、片剂脆碎度和片剂崩解时间均表现出色,并且在6种模型活性药物成分中仅在狭窄范围内变化。由这6种模型活性药物成分组成的片剂在水中几乎可以释放出100%的药物。因此,本文所述方法有望广泛应用于使用直接压片法开发具有优异CU和其他关键质量属性的低剂量片剂产品。